Elasty F — PNET Medium-Density HA Filler Without Lidocaine (2 × 1ml)

Elasty F is Dongbang Medical’s medium-density PNET cross-linked HA filler without lidocaine — 24 mg/mL pure hyaluronic acid formulation suited for practitioners managing separate anaesthesia or treating patients with lidocaine sensitivity. Engineered for mid-dermal and superficial placement targeting fine lines, periorbital wrinkles, and sensitive treatment areas. 2 × 1 mL syringes per box.

Elasty F Pure HA Filler for Sensitive Areas is manufactured by Dongbang Medical Co. Ltd., a South Korea-based medical device and pharmaceutical company established in 1995. The product is part of the Elasty dermal filler range, which is distributed across multiple international markets. Regulatory status: KFDA registered · CE marked · GMP certified.

Elasty F Pure HA Filler for Sensitive Areas contains 24 mg/mL of cross-linked hyaluronic acid plus 0.3% (3 mg/mL) premixed lidocaine for injection comfort. The hyaluronic acid is non-animal, produced by bacterial fermentation and cross-linked using Dongbang Medical Co. Ltd.’s PNET (Preserved Natural Entanglement Technology) technology. Phosphate-buffered saline at near-physiological pH carries the gel.

Per Dongbang Medical Co. Ltd.’s clinical data, Elasty F Pure HA Filler for Sensitive Areas delivers 6-9 months of correction depending on placement and patient factors. Duration depends on injection depth, dose, anatomical site, patient metabolism, and facial movement intensity. Mid dermis placement typically delivers the longer end of the duration range.

Elasty F Pure HA Filler for Sensitive Areas is engineered for mid dermis · superficial placement. The standard recommended needle is 27G UTW, supplied in the syringe blister pack. Some practitioners prefer a blunt-tip cannula of equivalent gauge for safer placement in highly vascular zones, particularly for deeper subcutaneous work.

Elasty F Pure HA Filler for Sensitive Areas regulatory status: KFDA registered · CE marked · GMP certified. The product’s KFDA registration in South Korea is the primary regulatory baseline. CE marking and other international approvals enable distribution in the EU and other regulated markets. US FDA status varies — buyers in regulated jurisdictions should verify approval scope before importation and clinical use.

Store Elasty F Pure HA Filler for Sensitive Areas between 2 °C and 25 °C in original packaging, away from direct sunlight. Do not freeze — freezing damages the HA gel structure. Shelf life is typically 24 months from the manufacturing date printed on the box when unopened. Once a syringe is opened, contents must be used immediately. Partial syringes cannot be retained for later use due to sterility risk.

No. Elasty F Pure HA Filler for Sensitive Areas uses non-animal hyaluronic acid produced by bacterial fermentation — the standard manufacturing approach for modern HA dermal fillers. The product contains no animal proteins or by-products, making it suitable for patients who avoid animal-derived medical products. The product is contraindicated in patients with severe allergies to gram-positive bacterial proteins (used in HA fermentation).

Yes — layered protocols combining different fillers are standard aesthetic practice. Elasty F Pure HA Filler for Sensitive Areas can be combined with other Korean or international HA fillers, neuromodulators (botulinum toxin), or biostimulators (PLLA, calcium hydroxylapatite) within a single session. Always wait the recommended interval between different injectable products and confirm biocompatibility per each manufacturer’s IFU.

Elasty F (no lidocaine) suits two specific scenarios: (1) patients with documented lidocaine hypersensitivity or contraindication, and (2) practitioners preferring tighter control over anaesthetic dosing — for example, when combining filler placement with nerve blocks or topical anaesthesia regimens. For most routine patients without lidocaine concerns, Elasty F Plus is preferred for injection comfort. Both variants share the same 24 mg/mL HA base and PNET cross-linking, differing only in lidocaine inclusion.